Aveanna Q4 revenue up 6.1% to $478.8M; adjusted EBITDA +30.4%; FY2024 guidance issued

Aveanna Healthcare Holdings, Inc.

Q4 revenue $478.8M (+6.1% YoY), driven by Private Duty Services and Medical Solutions growth; Home Health & Hospice down slightly.
Gross margin improved to 31.0% (28.5% a year ago); adjusted EBITDA $38.7M, up 30.4% from $29.7M.
Net loss narrowed to $25.7M from $237.8M, largely due to a $205.1M goodwill impairment in Q4 2022.
FY2024 revenue guidance $1.96B–$1.98B; adjusted EBITDA $146M–$150M.
CEO cites strong Q4 results and momentum from value-based care strategy and enhanced payor partnerships.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.